• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Aquestive Therapeutics, Inc. - Common Stock (NQ:AQST)

    4.260 -0.110 (-2.52%)
    Streaming Delayed Price Updated: 4:00 PM EST, Mar 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Aquestive Therapeutics, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    News headline image
    Investor Notice: Robbins LLP Informs Investors of the Aquestive Therapeutics, Inc. Class Action Lawsuit
    From Robbins LLP
    Via Business Wire
    News headline image
    Aquestive (AQST) Q4 2025 Earnings Call Transcript ↗
    Aquestive (AQST) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings Lawsuit
    Aquestive Therapeutics Inc (NASDAQ:AQST) Reports Mixed Q4 2025 Results and Anaphylm Regulatory Update ↗
    Via Chartmill
    News headline image
    Aquestive Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    AQST SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Aquestive Therapeutics to Participate in Upcoming March Investor Conferences
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Aquestive Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Aquestive Therapeutics to Present New Clinical Data on Anaphylm™ (dibutepinephrine) Sublingual Film at the 2026 AAAAI Annual Meeting
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    AQST SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
    From Pomerantz LLP
    Via GlobeNewswire
    Top movers in Monday's session ↗
    Via Chartmill
    Check out the stocks that are attracting the most attention and driving market activity. ↗
    Via Chartmill
    News headline image
    AQST Investors Have Opportunity to Join Aquestive Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Monday's session: top gainers and losers ↗
    Via Chartmill
    Monday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    Why Did AQST Stock Jump 35% Today? ↗
    The company received a Complete Response Letter from the U.S. Food and Drug Administration for its New Drug Application seeking approval of Anaphylm, a sublingual film to treat severe Type I allergic... 
    Via Stocktwits
    Monday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    AQUESTIVE ALERT: Bragar Eagel & Squire, P.C. is Investigating Aquestive Therapeutics, Inc. on Behalf of Aquestive Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox & Kilsheimer LLP is Investigating Aquestive Therapeutics, Inc. (AQST) for Potential Securities Law Violations
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    News headline image
    Kaplan Fox &amp; Kilsheimer LLP is Investigating Aquestive Therapeutics, Inc. (AQST) for Potential Securities Law Violations
    Via TheNewswire.com
    News headline image
    INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.